PROGRESSIVE IMPAIRMENT OF LUNG IMMUNITY IN HIV INFECTION

Project: Research project

Description

DESCRIPTION Most patients with HIV infection will have an infectious pulmonary complication at some point during the course of their disease. However, these are usually a late manifestation of HIV infection, not appearing until CD4 counts fall well below 500 cells/ul and often below 200 cells/ul. HIV-infected patients frequently have an accumulation of CD8+ cytotoxic T lymphocytes (CTL) in the alveolar space which appears early and persists until late in their disease course when they are replaced by CD8+ suppressor cells. This switch heralds the rapid progression of end stage HIV disease and is associated with an increased incidence of pulmonary infections. The changing CD8+ population could reflect a shift in phenotype from CTL to suppressor cells under the influence of cytokines and cells in the alveolar space, expansion of the suppressor cell population, or loss of CTL. Any of these changes may be mediated by HIV itself or in concert with other organisms raising the intriguing possibility that pulmonary infections themselves can induce the switch from CTL to suppressor cells in the alveolar space. For this proposal they hypothesize that the fundamental change in the lung environment which leads to an AIDS defining pulmonary infection occurs when CD8+ CTL are replaced by CD8+ suppressor cells. They propose to address this hypothesis using an in vitro Mycobacterium tuberculosis infection model. They speculate that the switch is caused by a complex interplay between cytokines, cells, HIV and infectious organisms in the alveolar space. In this proposal they will 1. Examine changes in alveolar cell immune function in patients at different stages of HIV infection with regards to cytokine secretion and the induction of cellular immune responses, 2. Determine if these changes mediate the CD8+ CTL to suppressor cell switch through apoptosis of CTL, expansion of suppressor cells, or induction of a direct phenotypic switch from one cell type to the other, 3. Determine if the switch from CD8+ CTL CD8+ suppressor cells in the alveolar space impairs the ability to kill Mycobacterium tuberculosis, and 4. Determine if Mycobacterium tuberculosis can induce the CD8+ CTL to CD8+ suppressor cell switch through alteration of alveolar macrophage and T cell function, induction of CD8+ suppressor cell expansion, induction of CD8+ CTL apoptosis, and/or upregulation of HIV expression. Understanding mechanisms behind the change in the alveolar compartment in HIV-infected patients with advanced disease will contribute substantially to our understanding about late HIV infection and its attendant increase in pulmonary morbidity as well as offer suggestions on novel immune based therapeutic strategies.
StatusFinished
Effective start/end date7/10/986/30/04

Funding

  • National Institutes of Health: $245,194.00
  • National Institutes of Health: $241,330.00
  • National Institutes of Health: $241,422.00
  • National Institutes of Health
  • National Institutes of Health: $248,992.00

Fingerprint

HIV Infections
Cytotoxic T-Lymphocytes
Immunity
Lung
Alveolar Epithelial Cells
HIV
Mycobacterium tuberculosis
Cytokines
Infection
Apoptosis
Mycobacterium Infections
Alveolar Macrophages
CD4 Lymphocyte Count
Cellular Immunity
Population
Acquired Immunodeficiency Syndrome
Up-Regulation
Morbidity
T-Lymphocytes
Phenotype

ASJC

  • Medicine(all)